<生产厂家价格>

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐名称

[ CAS 号 ]:
3883-94-1

[ 中文名 ]:
2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐

[ 英文名 ]:
2-(4-Methoxyphenyl)-2-oxoethanaminiumchlorid

[中文别名 ]:

2-氨基-4-甲氧基苯乙酮盐酸盐

[英文别名 ]:

2-Amino-4‘-methoxyacetophenone hydrochloride
2-(4-Methoxyphenyl)-2-oxoethanaminium chloride
2-amino-1-(4-methoxyphenyl)ethanone,hydrochloride
2-Amino-1-(4-methoxyphenyl)ethanone hydrochloride
2-Amino-4′-methoxyacetophenone hydrochloride
2-(4-Methoxyphenyl)-2-oxoethanaminiumchlorid
MFCD00193078

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐物理化学性质

[ 密度 ]:
1.111g/cm3

[ 沸点 ]:
315.4ºC at 760mmHg

[ 熔点 ]:
190-193ºC(lit.)

[ 分子式 ]:
C₉H₁₂ClNO₂

[ 分子量 ]:
201.650

[ 闪点 ]:
166ºC

[ 精确质量 ]:
201.055649

[ PSA ]:
52.32000

[ LogP ]:
2.33890

[ 外观性状 ]:
白色至黄色至黄色-黄褐色的结晶粉末

[ 储存条件 ]:
室温，干燥

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi: Irritant;

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
26-36

[ 危险品运输编码 ]:
NONH for all modes of transport

[ 海关编码 ]:
2922509090

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐合成路线

详细合成路线

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐上下游产品

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐上游产品

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐下游产品

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐海关

[ 海关编码 ]: 2922509090

[ 中文概述 ]:
2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件：AB. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装

[ 监管条件 ]: A.入境货物通关单 B.出境货物通关单

[ 检验检疫 ]: R.进口食品卫生监督检验 S.出口食品卫生监督检验

[ Summary ]:
2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

2-氨基-1-(4-甲氧苯基)-苯乙酮盐酸盐文献

Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer.

J. Pharmacol. Exp. Ther. 331(2) , 636-47, (2009)

A series of diaryl- and fluorenone-based analogs of the lead compound UA-62784 [4-(5-(4-methoxyphenyl)oxazol-2-yl)-9H-fluoren-9-one] was synthesized with the intention of improving upon the selective ...

UA62784, a novel inhibitor of centromere protein E kinesin-like protein.

Mol. Cancer Ther. 8 , 36-44, (2009)

Pancreatic carcinoma is the fourth leading cause of death from cancer. Novel targets and therapeutic options are needed to aid in the treatment of pancreatic cancer. The compound UA62784 is a novel fl...

更多文献